Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ophthalmology, Macular Degeneration”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Not applicableStudy completedNCT01447043
What this trial is testing

Study to Assess the Effectiveness of Existing Anti vascUlar Endothelial Growth Factor (Anti VEGF) in Patients With Wet Age-related Macular Degeneration (wAMD) (AURA)

Who this might be right for
Ophthalmology, Macular Degeneration
Bayer 2,609
Early research (Phase 1)Study completedNCT05262244
What this trial is testing

Targeted Fluorescence Imaging in AMD

Who this might be right for
Age-Related Macular DegenerationNAMD
University Medical Center Groningen 12
Testing effectiveness (Phase 2)Looking for participantsNCT05769153
What this trial is testing

Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Alcon Research 140
Not applicableStudy completedNCT00787319
What this trial is testing

Long-Term Non-Interventional Study (NIS) To Investigate The Safety And Effectiveness Of MACUGEN In Patients With Neovascular Age-Related Macular Degeneration Under Conditions Of Routine Clinical Practice

Who this might be right for
Age-related Macular Degeneration
Pfizer 108
Not applicableLooking for participantsNCT07519707
What this trial is testing

Video Intervention to Improve Understanding of Diabetic Retinopathy at Zuckerberg San Francisco General Hospital and Trauma Center

Who this might be right for
Diabetic Retinopathy (DR)Macular Edema (ME)
University of California, San Francisco 150
Not applicableStudy completedNCT00769392
What this trial is testing

Pilot Study: A Randomized Trial Of Anesthetic Agents For Intravitreal Injection

Who this might be right for
Macular Degeneration
Lahey Clinic 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT06164587
What this trial is testing

Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy

Who this might be right for
Geographic AtrophyAge-Related Macular Degeneration
Michelle Abou-Jaoude 30
Not applicableStudy completedNCT01318941
What this trial is testing

Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

Who this might be right for
Wet Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein OcclusionWet Age Related Macular DegenerationDiabetic Macular Edema+1 more
Novartis Pharmaceuticals 30,490
Not applicableStudy completedNCT02558712
What this trial is testing

Technology-based Eye Care Services (TECS) Compare

Who this might be right for
CataractMacular DegenerationGlaucoma
Emory University 256
Not applicableLooking for participantsNCT06914778
What this trial is testing

Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and Retinopathy in South Wales

Who this might be right for
Diabetic Retinopathy (DR)Diabetic Retinopathy Associated With Type 2 Diabetes MellitusDiabetic Macular Edema (DME)
Hywel Dda Health Board 120
Not applicableUnknownNCT03750149
What this trial is testing

Reading Analysis in Ophthalmologic Patients

Who this might be right for
Diabetic MaculopathyAge Related Macular DegenerationGlaucoma+1 more
Prim. Prof. Dr. Oliver Findl, MBA 100
Not applicableStudy completedNCT01771081
What this trial is testing

Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy

Who this might be right for
OphthalmologyMacular EdemaMacular Degeneration
Bayer 911
Not applicableStudy completedNCT04067583
What this trial is testing

A Follow-up Physician Survey to Evaluate Physician Knowledge of Safety and Safe Use Information for Aflibercept Administered by Intravitreal Injection in Europe

Who this might be right for
Ophthalmology, Macular Degeneration
Bayer 454
Not applicableUnknownNCT01920867
What this trial is testing

Stem Cell Ophthalmology Treatment Study

Who this might be right for
Retinal DiseaseMacular DegenerationHereditary Retinal Dystrophy+2 more
MD Stem Cells 300
Not applicableNot Yet RecruitingNCT06817915
What this trial is testing

This Project At LMU Looks At How Using AI 2nd Opinion Report to Analyze Retinal Eye Scans Impact Doctors' Decisions About Treatment for Patients with a Specific Eye Disease (nAMD)

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
Johannes Schiefelbein 100
Testing effectiveness (Phase 2)Ended earlyNCT02485249
What this trial is testing

Open-label, Multli-center, Phase 1b/2a Clinical Trial Designed to Evaluate the Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients With Macular Edema

Who this might be right for
Macular Edema
Eyegate Pharmaceuticals, Inc. 25
Not applicableLooking for participantsNCT03011541
What this trial is testing

Stem Cell Ophthalmology Treatment Study II

Who this might be right for
Retinal DiseaseAge-Related Macular DegenerationRetinitis Pigmentosa+15 more
MD Stem Cells 500
Not applicableStudy completedNCT06495203
What this trial is testing

Understand the Usage of an Artificial Intelligence Technology Called DARWEN for Eye Disorders and to Find Out the Factors Influencing Treatment Frequencies in People With nAMD and RVO

Who this might be right for
Neovascular Age-related Macular DegenerationRetinal Vein Occlusion
Bayer 1,350
Large-scale testing (Phase 3)Study completedNCT01535261
What this trial is testing

Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion

Who this might be right for
Macular EdemaCentral Retinal Vein Occlusion
Novartis Pharmaceuticals 357
Not applicableLooking for participantsNCT07084883
What this trial is testing

Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration (AMD)
iHealthScreen Inc 1,076
Load More Results